Masuma Mishu from the Closing the Gap Network reviews a recent US trial of a comprehensive cardiovascular risk reduction intervention in people with severe mental illness, which shows promising results.
[read the full story...]
Masuma Mishu from the Closing the Gap Network reviews a recent US trial of a comprehensive cardiovascular risk reduction intervention in people with severe mental illness, which shows promising results.
[read the full story...]
Gordon Johnston and Michel Syrett prepare for the #HealthSMI event on 24th June by blogging about a recent pilot RCT of a health coaching intervention (Walk This Way) to reduce sedentary behaviour and increase physical activity in people with serious mental illness.
[read the full story...]
Paul Heron from the Closing the Gap Network writes his debut blog about a 20‐year cohort study of physical morbidity and mortality in relationship to antipsychotic treatment in a huge group of people with schizophrenia in Finland.
[read the full story...]
A group of Masters Students from the University of Glasgow Global Mental Health MSc write about the Primrose trial, which looked at the clinical and cost-effectiveness of an intervention for reducing cholesterol and cardiovascular risk in severe mental illness.
[read the full story...]
Peter Haddad and Sami Ouanes review a network meta-analysis of the impact of antipsychotic drugs on metabolic function in people with schizophrenia.
[read the full story...]
Emily Peckham from the Closing The Gap Network writes her debut blog on a new systematic review, which finds that people with mental illnesses were less likely to receive screening for cancer compared to the general population.
[read the full story...]
Ian Hamilton looks at a Swedish 42-year follow-up study, which looks at the impact that psychiatric comorbidity can have on premature death in a cohort of patients with substance use disorders.
[read the full story...]
Lina Gega from the Closing the Gap Network explores a recent review of digital technology for health promotion, which looks at opportunities to address excess mortality in people living with severe mental illness.
[read the full story...]
David Shiers and Peter Byrne summarise the new SCIMITAR+ trial out today in The Lancet Psychiatry, which evaluates a bespoke smoking cessation intervention for people with severe mental illness.
[read the full story...]
Dafni Katsampa explores a recent prospective cohort study that investigates the association between smoking behaviour and cognitive functioning in patients with psychosis, their siblings and healthy control subjects.
[read the full story...]